Argenx Raises $1.1B in Global Offering for Immunology Advancements

Amsterdam, Netherlands, July 19, 2023 (Globe Newswire) -- Argenx, a global immunology company, has priced a global offering to anticipating approximately $1.1 billion in total gross proceeds. The company aims to drive advancements in severe autoimmune disease treatments.

Read full article here.